Login
Suchergebnis (1-20 von 46)Download
|
Symbol
|
RMABXV | YOTLTQ | OCGRCH | LTHCLK | RMBE8V | AAIETQ | AAXSTQ | PBVRCH | RMA3QV | LJSULK | ABSFTQ | RMAHBV | CQWBKB | LXWCLK | SKS6LK | RMAAHV | QDPRCH | LZJRCH | ADRATQ | LZQRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | LUKB Multi Reverse Convertible | Worst of Reverse Convertible | Multi Vonti | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible |
|
Basiswert
|
Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Nestlé / Novartis | Nestlé S.A. / Novartis AG / Roche PS | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Novartis AG / Roche PS / Vodafone Group Plc. | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N | Galderma Group AG / Novartis AG / Sika AG | Holcim/Amrize Basket / Novartis AG / Roche PS / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Givaudan / Novartis AG / Sandoz Group AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
12.10.2026 | 24.11.2027 | 26.04.2027 | 09.07.2027 | 13.07.2026 | 19.07.2027 | 13.09.2027 | 21.04.2027 | 09.11.2026 | 19.11.2026 | 20.12.2027 | 10.07.2026 | 13.03.2028 | 25.03.2027 | 07.04.2027 | 26.04.2027 | 16.05.2028 | 24.07.2026 | 04.08.2028 | 07.08.2029 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
77.13 | 74.2425 | 58.5776 | 58.7776 | 83.70 | 52.063 | 43.77 | 56.28 | 56.14 | 62.176 | 37.59 | 229.60 | 78.705 | 76.296 | 174.48 | 419.90 | 65.7375 | 52.26 | 35.72 | 2'627.25 |
|
Maximal- rendite p.a. |
9.51% | 6.10% | 3.93% | 5.49% | 61.27% | 1.43% | 2.67% | 4.10% | 26.63% | 1.10% | 2.39% | -0.45% | 9.96% | 7.46% | 25.12% | 4.75% | 5.80% | 27.11% | 3.44% | 5.78% |
| Geld | 98.10 | 98.58 | 99.07 | - | 95.30 | 100.90 | 101.05 | 99.11 | 91.70 | - | 101.21 | 99.86 | 92.92 | - | - | 100.00 | 98.63 | 96.91 | 99.20 | 96.06 |
| Brief | 99.10 | 99.38 | 99.87 | - | 96.60 | 101.71 | 101.86 | 99.91 | 92.70 | - | 102.02 | 101.10 | 93.72 | - | - | 101.00 | 99.43 | 97.71 | 100.00 | 96.86 |
Bitte warten...
Der Kursdaten-Push wurde aufgrund einer Zeitüberschreitung deaktiviert. Bitte klicken Sie auf "Seite aktualisieren", um fortzufahren.
Ihr Merkzettel (0)